ClinicalTrials.gg
CompletedNCT06082830HEALTHY BITESUpdated Oct 27, 2026Results posted

Helping Educate and Advance Learning Through Healthy Bite-Sized Eating Strategies

An interventional study of Intervention in Adolescent Obesity, Adolescent Overweight and Diet, Healthy, sponsored by Children's Hospital of Philadelphia. Completed at 1 site in United States. Open to participants aged 14 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-10-27.

Sponsored by Children's Hospital of Philadelphia · Not applicable, Interventional, and Treatment

How we know

Updated Oct 27, 2026Results postedStudy documents posted+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
14 Years to 17 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 558 studies in Pediatric Obesity with a site in United States — 72 open to participants now, 109 under way, 3 of them phase 3. Pediatric Obesity · United States.

Enrollment
430th of 475
15 · median 95
Started
2024
with 32 others
No phase
423 of 558
50 open now
Registered
484th of 558
by date

Among the 558 studies in Pediatric Obesity with a site in United States, this one is the 430th largest by enrollment of the 475 interventional ones that give a count, is one of 33 that started in 2024, is one of 423 with no phase, and was the 484th registered.

Pediatric Obesity

1,132 studies on the registry are indexed under Pediatric Obesity; 183 are open to participants now.

Browse Pediatric Obesity studies →

Open to participants now

72 of the 558 studies in Pediatric Obesity with a site in United States are open now. Recruiting first, the newest first:

67 more — sign in →

All 72 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 119 Pediatric Obesity studies recruiting now, 16 (13%) set no upper age limit and 101 (85%) stop at 75 or younger; 110 take children under 18; 67 take healthy volunteers.

This study: 14 Years to 17 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 558 studies in Pediatric Obesity with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial is to compare the effectiveness of a mobile health intervention in adolescents (14-17 years) with overweight or obesity.

The main question[s] it aims to answer are: 1) is a digital-based diet quality intervention for adolescents with overweight or obesity feasible and 2) is there preliminary effectiveness in improving diet quality?

Participants will:

  1. Complete three-day 24-hour dietary recalls
  2. Collect urine samples
  3. Wear a continuous glucose monitor, sleep tracker, and physical activity tracker

Researchers will compare control and intervention groups to see if diet quality and meal timing traits improve as assessed by 24-hour dietary recalls, a novel urine biomarker, and continuous glucose monitoring (CGM).

Read the detailed description

Background:

Improving diet quality is an essential component for the treatment of adolescent obesity. Pediatric providers are recommended to incorporate nutrition recommendations as part of adolescent obesity treatment, but time and knowledge are barriers. Digital-based interventions have been shown to improve fruit and vegetable intake in adolescents. However, it is unknown if a digital-based diet quality intervention is feasible or effective for adolescents with overweight or obesity.

Objectives: (primary and important secondary objectives) The overarching objective of this pilot study is to demonstrate if a digital-based diet quality intervention for adolescents with overweight or obesity is feasible and if there is preliminary effectiveness that diet quality and meal timing traits improves as assessed by 24-hr dietary recalls, a novel urine biomarker, and continuous glucose monitoring (CGM).

Study Design:

A two-arm pilot randomized controlled trial (RCT) falling under the preparation phase of the Multiphase Optimization Strategy (MOST) framework.

Setting/Participants:

This is a single site study. Adolescents (N=70, aged 14-17 years) at risk for diet quality that is low or in need of improvement (Healthy Eating Index (HEI) \< 80) and with a history of having overweight or obesity (body mass index (BMI) between the 85th and 99th percentile on at least two occasions six months apart in the medical record in the last five years) will be invited to participate. Clinical measurements will be acquired at the Children's Hospital of Philadelphia (CHOP). Diet, urine, blood glucose, physical activity, and sleep data collection will take place in the home setting.

Study Interventions and Measures:

Adolescents and their parents will be randomized to receive a) usual care or b) a nutrition intervention with personal goals, meal timing, nutrition skills, and home food environment intervention components. The content for each component will be delivered through text messaging. Three 24-hr dietary recalls and the first morning urine void on two separate occasions will be collected at baseline and follow-up. HEI-2020 scores will be calculated and change in HEI-2020 will be the primary outcome. The urine Na:K will be quantified and change in Na:K will be the secondary outcome.

03

Conditions studied

  • Adolescent Obesity
  • Adolescent Overweight
  • Diet, Healthy

Browse trials for

04

Who can participate

Ages eligible
14 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 14-17 years old.
  • At risk for diet quality that is poor or needs improvement (HEI score \< 80) determined by participants baseline 24-hour diet recall data.
  • between the 85th and 99th percentile for age and sex on at least two occasions at least six months apart in the medical record in the last five years.
  • Have access to a phone capable of receiving text messages.

Exclusion criteria

Exclusion Criteria:

  • History of an eating disorder diagnosis (e.g., anorexia nervosa, bulimia nervosa, binge eating disorder, avoidant restrictive food intake disorder).
  • History of a condition that may alter dietary intake (e.g., diabetes, Celiac's disease, phenylketonuria, cystic fibrosis).
  • Regularly taking medications that may result in weight loss, appetite stimulation or suppression, and/or fluctuations in fluid status.
  • Currently being followed by a registered dietitian.
  • Pregnant or lactating females.
  • Have a parent, guardian, or family member that works for the Division of Gastroenterology, Hepatology, and Nutrition at CHOP.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
15 participants (actual)

Study arms

  • No intervention
    Control

    The control arm will not receive any intervention materials.

  • Experimental
    Intervention

    The trial duration will be four weeks. The intervention arm includes five components: personalized goal, meal timing, nutrition skills, home food environment, and engagement strategies. The specific number, design and content of the text messages for each component will be prepared and vetted by the investigators and by adolescents and parents through CHOP's Family Partners Program prior to study launch. The text messages will be sent through the REDCap Twilio integration.

    Behavioral: Intervention

Interventions

  • BehavioralIntervention

    The intervention arm includes five components: 1. Personalized goal: Participants will complete an interview with a registered dietitian to review their baseline diet quality data and establish their personalized dietary goals. 2. Meal timing: Participants will receive information on why eating later at night is detrimental and specific strategies on how to limit eating past 8pm in the evening. 3. Nutrition skills: Participants will receive nutrition education and cooking skills text messages, using adolescent specific guidance from the Dietary Guidelines for Americans. 4. Home food environment: Participants will receive text messages on how to better select and prepare foods in the home environment (e.g., fruit and vegetable availability). 5. Engagement strategies: Researchers will design and implement text messages that recognize participant time and effort (e.g., text badges in recognition of completing the first study week).

06

What researchers measure

Primary outcomes

  1. Diet Quality

    For aim 1, the primary outcome will be change in overall Healthy Eating Index (HEI) 2020 score. The HEI-2020 ranges from 0-100; a greater score indicates greater adherence to the 2020 - 2025 Dietary Guidelines for Americans and better diet quality. HEI-2020 scores will be derived from dietary data collected through three 24-hour dietary recalls at baseline and follow-up and processed using Nutrient Data System for Research software. Outcome measure data were collected for adolescents only, not caregivers.

    Time frame: 6 weeks

Secondary outcomes

  1. Urinary Concentration of Sodium (Na)

    For aim 2, outcome 2 will be change in urinary Na. Participants will collect their urine from their first morning voids at baseline and follow-up. The urine will be sent to CHOP for biobanking and proton nuclear magnetic resonance (NMR) will be used to measure Na. This provides an objective measure of high sodium (e.g., processed foods) in the diet. Outcome measure data were collected for adolescents only, not caregivers.

    Time frame: 6 weeks

  2. Urinary Concentration of Potassium (K)

    For aim 2, outcome 3 will be change in urinary K. Participants will collect their urine from their first morning voids at baseline and follow-up. The urine will be sent to CHOP for biobanking and proton nuclear magnetic resonance will be used to measure K. This provides an objective measure of high potassium (e.g., fruits and vegetables) in the diet. Outcome measure data were collected for adolescents only, not caregivers.

    Time frame: 6 weeks

07

Results

Posted Oct 27, 2026

Participant flow

Participant flow — Overall Study
MilestoneControlInterventionNot Randomized
Started771
Completed770
Not completed001
Withdrew: Ineligible after baseline diet assessment001

Outcome measures

PrimaryDiet Quality

For aim 1, the primary outcome will be change in overall Healthy Eating Index (HEI) 2020 score. The HEI-2020 ranges from 0-100; a greater score indicates greater adherence to the 2020 - 2025 Dietary Guidelines for Americans and better diet quality. HEI-2020 scores will be derived from dietary data collected through three 24-hour dietary recalls at baseline and follow-up and processed using Nutrient Data System for Research software. Outcome measure data were collected for adolescents only, not caregivers.

Time frame:
6 weeks
Reported as:
Mean · units on a scale
Diet Quality
units on a scaleControl (Adolescents)Intervention (Adolescents)
Baseline53.4 ± 9.147.6 ± 8.0
Follow-Up44.7 ± 9.442.6 ± 8.7
Statistical analysis
  • Control (Adolescents) vs Intervention (Adolescents) · Regression, Linear · p = 0.182 · Slope: 5.302 · 95% CI -2.49 to 13.09The estimate represents the study arm (intervention, control) by time (baseline, follow-up) interaction.
SecondaryUrinary Concentration of Sodium (Na)

For aim 2, outcome 2 will be change in urinary Na. Participants will collect their urine from their first morning voids at baseline and follow-up. The urine will be sent to CHOP for biobanking and proton nuclear magnetic resonance (NMR) will be used to measure Na. This provides an objective measure of high sodium (e.g., processed foods) in the diet. Outcome measure data were collected for adolescents only, not caregivers.

Time frame:
6 weeks
Reported as:
Mean · mmol/L
Urinary Concentration of Sodium (Na)
mmol/LControlIntervention
Baseline114.4 ± 22.8161.6 ± 50.9
Follow-Up120.0 ± 36.7152.9 ± 86.7
Statistical analysis
  • Control vs Intervention · Regression, Linear · p = 0.295 · Slope: -24.406 · 95% CI -70.086 to 21.274The estimate represents the study arm (intervention, control) by time (baseline, follow-up) interaction.
SecondaryUrinary Concentration of Potassium (K)

For aim 2, outcome 3 will be change in urinary K. Participants will collect their urine from their first morning voids at baseline and follow-up. The urine will be sent to CHOP for biobanking and proton nuclear magnetic resonance will be used to measure K. This provides an objective measure of high potassium (e.g., fruits and vegetables) in the diet. Outcome measure data were collected for adolescents only, not caregivers.

Time frame:
6 weeks
Reported as:
Mean · mmol/L
Urinary Concentration of Potassium (K)
mmol/LControlIntervention
Baseline38.8 ± 14.040.4 ± 16.7
Follow-Up45.6 ± 19.167.4 ± 22.4
Statistical analysis
  • Control vs Intervention · Regression, Linear · p = 0.162 · Slope: 19.168 · 95% CI -7.702 to 46.039The estimate represents the study arm (intervention, control) by time (baseline, follow-up) interaction.

Adverse events

Collected over From enrollment until end of follow-up, up to 7 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Control0/7 (0%)0/7 (0%)0/7 (0%)
Intervention0/7 (0%)0/7 (0%)0/7 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(Years)Control (Adolescent)Control (Caregiver)Intervention (Adolescent)Intervention (Caregiver)Not Randomized (Adolescent)Not Randomized (Caregiver)Total
Mean—45.57 ± 8.23—43.71 ± 5.79—5445.27 ± 7.10
Age, Customized
Age, Customized(Participants)Control (Adolescent)Control (Caregiver)Intervention (Adolescent)Intervention (Caregiver)Not Randomized (Adolescent)Not Randomized (Caregiver)Total
14 years4030007
15 years1010103
16 years1020003
17 years1010002
Sex/Gender, Customized
Sex/Gender, Customized(Participants)Control (Adolescent)Control (Caregiver)Intervention (Adolescent)Intervention (Caregiver)Not Randomized (Adolescent)Not Randomized (Caregiver)Total
Female46561123
Male3121007
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Control (Adolescent)Control (Caregiver)Intervention (Adolescent)Intervention (Caregiver)Not Randomized (Adolescent)Not Randomized (Caregiver)Total
American Indian or Alaska Native0000000
Asian1000001
Native Hawaiian or Other Pacific Islander0000000
Black or African American1021116
White47250018
More than one race1030004
Unknown or Not Reported0001001
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Control (Adolescent)Control (Caregiver)Intervention (Adolescent)Intervention (Caregiver)Not Randomized (Adolescent)Not Randomized (Caregiver)Total
Hispanic or Latino1000001
Not Hispanic or Latino66771128
Unknown or Not Reported0100001
08

Study locations

1 site
  • Children's Hospital of Philadelphia
    Philadelphia, Pennsylvania 19146, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — The participants will be asked to collect their first morning void on two occasions at baseline and follow-up. Participants will be provided with towelette(s) and a pre-labeled urine collection cup and provided with sex-specific instructions to collect clean-catch urine. Samples will be shipped from participants' homes to the CHOP Biorepository Center for processing, aliquoting, and biobanking. De-identified samples will be shipped to Penn State University for proton nuclear magnetic resonance (NMR) analysis.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2024 to primary completion in Jun 2025, 8 months.

Results were first posted in Oct 2026, 1 year 4 months after primary completion.

Of 542 non-industry interventional studies with no phase under Pediatric Obesity, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 45. This study's 8 months is below that.

Counting every sponsor, half of 544 studies reached it within 25 months; a quarter within 11 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 9, 2023
First posted
Oct 13, 2023
StartActual
Oct 1, 2024
Primary completionActual
Jun 14, 2025
CompletionActual
Jun 14, 2025
Results first posted
Oct 27, 2026
Last update
Oct 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Oct 27, 2026
Enrollment
86→15
Oct 27, 2026
Primary outcomes
1 description edited
What changed in the outcomes
  • DescriptionDiet Quality: how it is measured was reworded
Oct 27, 2026
Secondary outcomes
2 description edited
What changed in the outcomes
  • DescriptionUrinary Concentration of Potassium (K): how it is measured was reworded
  • DescriptionUrinary Concentration of Sodium (Na): how it is measured was reworded
Oct 27, 2026
Show all 1 update
  1. Oct 27, 2026
    Results posted
    Enrollment 86→15
    Primary outcomes 1 description edited
    What changed in the outcomes
    • DescriptionDiet Quality: how it is measured was reworded
    Secondary outcomes 2 description edited
    What changed in the outcomes
    • DescriptionUrinary Concentration of Potassium (K): how it is measured was reworded
    • DescriptionUrinary Concentration of Sodium (Na): how it is measured was reworded
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT06082830
Responsible party
Sponsor
First posted
Oct 13, 2023
Start date
Oct 1, 2024
Primary completion
Jun 14, 2025
Completion
Jun 14, 2025
Results posted
Oct 27, 2026
Last update
Oct 27, 2026

Study contacts

Jonathan A Mitchell, PhD
principal investigator · Children's Hospital of Philadelphia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion